Fasting Mimicking Diet Cycles, Multi System Reprogramming and Disease | 11 March 2026

Why It Matters

FMD provides a practical, drug‑free method to reverse key aging biomarkers and reduce reliance on chronic medications, positioning diet‑based interventions as a frontline tool for extending healthspan.

Key Takeaways

• Intermittent fasting mimicking diet (FMD) replicates calorie restriction benefits.
• Five-day monthly FMD improves metabolic markers without lean mass loss.
• Mouse studies show FMD restores lifespan despite high‑fat diet.
• Human trials demonstrate FMD reduces insulin, IGF‑1, and medication use.
• FMD triggers embryonic gene programs, suggesting cellular rejuvenation.

Summary

The video presents Dr. [Speaker] overview of the fasting‑mimicking diet (FMD) as a periodic, low‑calorie, low‑protein, high‑fat regimen designed to capture the metabolic benefits of prolonged water fasting while avoiding its practical and safety drawbacks. He frames the approach within the broader agenda of treating aging itself, contrasting traditional risk factors such as smoking and obesity with the cumulative damage of thirty years of physiological aging.

He reviews landmark data: a 30‑year caloric‑restriction study in rhesus monkeys that cut diabetes incidence from 60 % to 5 % and halved tumor rates, yet only modestly extended overall survival, highlighting trade‑offs of chronic restriction. In mouse models, a five‑day monthly FMD given alongside a Western high‑fat diet restored cholesterol, reduced visceral fat, preserved lean mass, and nearly normalized lifespan compared with mice on a healthy diet. Human crossover trials (100 participants, three FMD cycles) showed comparable weight‑loss and fat‑reduction without lean‑mass loss, and most pre‑diabetic subjects returned to normal glycemia.

The speaker cites the Biosphere 2 calorie‑restriction experiment and recent mechanistic work showing that FMD transiently activates embryonic developmental genes—including Yamanaka‑related pathways—in damaged pancreas, prompting regeneration of insulin‑producing β‑cells. Clinical data also reveal that FMD lowered IGF‑1, CRP, and blood pressure, and enabled 70 % of diabetic patients to cut or discontinue glucose‑lowering drugs, outperforming a short‑term Mediterranean diet.

These findings suggest that periodic metabolic stress can re‑program multiple organ systems, offering a scalable, diet‑based strategy to mitigate age‑related disease without the muscle loss associated with continuous calorie restriction. If replicated in larger, longer‑term studies, FMD could become a cornerstone of preventive medicine, reshaping guidelines for metabolic health, chronic disease management, and possibly extending healthspan.

Original Description

This Stanford Department of Medicine Grand Rounds (MGR) presentation is entitled "Fasting Mimicking Diet Cycles, Multi System Reprogramming and Disease," and took place March 11, 2026 on Stanford campus.

Presenter Valter Longo, MD, is a world-renowned professor of gerontology and biological sciences at the University of Southern California, whose work on fasting-mimicking diets and the molecular mechanisms of longevity is revolutionizing approaches to healthy aging and disease prevention.

Learn more about the MGR series at: https://medicine.stanford.edu/education/medical-grand-rounds.html